Late lumen loss after treatment of coronary bifurcation lesions with a drug-eluting balloon in patients with symptomatic ischemic heart disease

Trial Profile

Late lumen loss after treatment of coronary bifurcation lesions with a drug-eluting balloon in patients with symptomatic ischemic heart disease

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms BIOLUX-I
  • Sponsors BIOTRONIK
  • Most Recent Events

    • 06 Mar 2014 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
    • 27 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top